Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2022
Todos Medical completes acquisition of 3CL protease assets
Todos Medical announced that it completed the acquisition of all 3CL protease biology-related assets from NLC Pharma and formed majority-owned subsidiary 3CL Pharma Ltd.
2021
Todos Medical retains iiiNTENT marketing service
Todos Medical said it retained iiiNTENT's artificial-intelligence software-as-a-service marketing service for Tollovid and Tollovid Daily products.
2021
Todos Medical appoints vice president of marketing
Todos Medical announced the appointment of Valentino Smith as its Vice President of Marketing.
2020
Todos Medical enters U.S. test distribution agreement
Todos Medical announced an agreement with a South Korean manufacturer for U.S. distribution rights to its rapid SARS-CoV-2 antigen and PCR tests.